Why Does Biologics Localization in the GCC Matter for Sovereign Capability? For more than a decade, Gulf governments have
Why Does Biologics Localization in the GCC Matter for Sovereign Capability? For more than a decade, Gulf governments have
Abstract This article examines how modular GMP design reshapes facility development across Oman and the GCC. It explains how
Abstract This article analyzes the financial framework shaping CAR-T cell therapy manufacturing across Oman and the Gulf Cooperation Council. It
Abstract This article analyzes the transformation of Oman’s and the GCC’s pharmaceutical oversight systems through enhanced data integrity and digitized
Oman’s Launch Pad: How OBP Is Building the Region’s Flagship for Biologics and Cell/Gene Therapy Oman is entering a decisive
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
Introduction The realm of oncology in The Middle East and North Africa (MENA) is a narrative of constant evolution, striving to meet the growing demands
